Don't let this divert from the fact that PYC is poised to hand candidates over to Genetech in the very near future (now since overdue) potentially worth up to $142M as part of the antimicrobial milestone agreement or the fact that Genetech are one of it not the most innovative company's when it comes to oncology and cancer drug research . Quite plausible that they will expand the current alliance further through oncology targets under their Roche / Genetech banner.
"Several promising candidates have been identified during the screening process, which is expected to conclude by October, 2015"
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
0.005(0.40%) |
Mkt cap ! $740.7M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.29 | $1.27 | $406.0K | 319.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13987 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 1380 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |